ELEVATION ONCOLOGY Trademark

Trademark Overview

On Friday, March 20, 2020, a trademark application was filed for ELEVATION ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ELEVATION ONCOLOGY trademark a serial number of 88841687. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Saturday, November 30, 2024. This trademark is owned by Elevation Oncology, Inc.. The ELEVATION ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer

Research and development in the field of pharmaceuticals and oncology for treatment of cancer

General Information

Serial Number88841687
Word MarkELEVATION ONCOLOGY
Filing DateFriday, March 20, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSaturday, November 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer
NOT AVAILABLE"ONCOLOGY"
Goods and ServicesResearch and development in the field of pharmaceuticals and oncology for treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 24, 2020
Primary Code005
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 24, 2020
Primary Code042
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020

Trademark Owner History

Party NameElevation Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10106
Party NameElevation Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10106

Trademark Events

Event DateEvent Description
Tuesday, March 24, 2020NEW APPLICATION ENTERED
Tuesday, March 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 12, 2020ASSIGNED TO EXAMINER
Friday, June 19, 2020NON-FINAL ACTION WRITTEN
Friday, June 19, 2020NON-FINAL ACTION E-MAILED
Friday, June 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 12, 2021SUSPENSION LETTER WRITTEN
Tuesday, January 12, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, January 12, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 2, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 5, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 11, 2024SOU EXTENSION 1 FILED
Monday, March 11, 2024SOU EXTENSION 1 GRANTED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024USE AMENDMENT FILED
Tuesday, September 3, 2024TEAS STATEMENT OF USE RECEIVED
Monday, November 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, November 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, November 30, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 30, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

oncology elevation cancer treatment pharmaceuticals field research preparations pharmaceutical development